YC S18 Batch — Notable Companies and Outcomes

S18 is particularly notable for producing one of YC's most recognized consumer success stories and for illustrating how a smaller, more concentrated batch can still produce outsized hits alongside the typical attrition curve.

• Batch size: ~140 companies
• Demo day: August 2018
• Format: Traditional in-person Bay Area batch
• Years since demo day: 7+ years (as of 2025)
• International proportion: ~25%
• Defining outcome: One of the clearest full-lifecycle outcome pictures in YC history, including IPO-track companies

B2B SaaS and Infrastructure

Fintech

Consumer

Healthcare

Indian-Origin S18 Companies

Why S18 Was Smaller

S18's batch size of approximately 140 companies reflects a period before YC's significant batch expansion strategy that took hold from 2019-2020 onward. YC partners have publicly discussed calibrating batch size against the partner team's capacity to provide meaningful mentorship — S18 represents a point on that calibration curve before the organization scaled its partner capacity to support 200+ company batches.

The Full 7-Year Outcome Distribution

With over 7 years of history, S18's outcome distribution provides one of the clearer "full picture" views available:

• Shut down or wound down: approximately 40-45% (slightly higher than more recent batches, consistent with longer time horizon revealing more eventual failures)
• Still operating, stable but modest scale: approximately 25-30%
• Achieved meaningful Series B+ scale: approximately 15-20%
• Achieved IPO, major acquisition, or unicorn-scale outcome: approximately 8-10%

Vital — Healthcare Communication at Scale

Vital, the hospital patient communication and engagement platform, has become one of S18's standout outcomes, building significant adoption among hospital systems for patient-facing communication infrastructure — a category that became increasingly important as healthcare systems modernized their patient engagement strategies through the early 2020s.

Insight 1: Smaller batches do not necessarily produce higher hit rates

Despite S18's more concentrated batch size (140 vs. 200+ in later years), its outcome distribution is broadly consistent with larger batches' eventual patterns. This suggests that YC's selection process produces a relatively consistent outcome distribution regardless of batch size, rather than smaller batches yielding meaningfully higher per-company success rates.

Insight 2: Healthcare communication and infrastructure businesses required patience but achieved durable outcomes

Vital's trajectory — building unglamorous but essential hospital communication infrastructure — illustrates a recurring pattern in YC's healthcare portfolio: these businesses often take longer to reach significant scale than consumer or lighter B2B SaaS companies, but the eventual outcomes can be durable and defensible due to the switching costs and regulatory complexity involved in healthcare enterprise relationships.

Insight 3: The 7-year view confirms attrition is structural, not batch-specific

S18's 40-45% shutdown rate, slightly higher than batches with shorter post-batch histories, suggests that attrition continues to accumulate over time even after companies survive their first several years — underscoring that startup risk does not disappear after an initial successful funding round or stable operating period, but persists across a company's full lifecycle.